MRC Public Health Intervention Development Scheme (PHIND)
Wednesday, 06 November 2013 09:53
The Public Health Intervention Development scheme (PHIND) is a new MRC funding scheme designed specifically to provide support for early phase development of public health interventions. This rapid response funding scheme is aimed at improving the initial evidence on which the development and evaluation of public health interventions are based. Studies should address an important UK or global public health issue and offer an innovative approach to intervention development or applying an existing intervention in a new setting.
The scheme's remit ranges from primary research developing and designing the intervention to feasibility studies, encompassing:
- developing theory
- modelling process and outcomes
- assessing feasibility
Systematic reviews, meta analyses and pilot studies are outside the remit of the PHIND scheme. Applicants can apply for up to £150K for a maximum of 18 months and the scheme will operate three times a year. For further information, please see the MRC website.
HCV clinical trial and tissue biobank
Wednesday, 16 October 2013 11:59
National Institute for Health Research announces hospital trusts to host branches of the Clinical Research Network
Wednesday, 02 October 2013 11:15
The Department of Health, through the National Institute for Health Research (NIHR), has announced the15 hospital Trusts that will host the local branches of the NIHR Clinical Research Network from April 2014. The 15 Trusts will take responsibility for performing the remit of the NIHR Clinical Research Network at local level and collectively will distribute £280 million of NIHR funding per year, to support the delivery of clinical research studies in their area.
Cross-government antimicrobial resistance strategy published
Wednesday, 02 October 2013 11:13
A five-year cross-government strategy has been published to manage the increasing problem of antimicrobial resistance (AMR).
It aims to slow the development and spread of AMR by focusing activities around three strategic aims:
- improve the knowledge and understanding of AMR
- conserve and steward the effectiveness of existing treatments
- stimulate the development of new antibiotics, diagnostics and novel therapies
The strategy also provides £4million to set up a new NIHR Health Protection Research Unit which will focus on AMR and healthcare associated infections and a themed research call to encourage AMR research across a range of areas.
Page 6 of 11